The first step to making the off-label drug safer for children is by ensuring the approval of clinical trials. The clinical trials help identify the safety of off–label drugs for pediatric patients (Rosenthal & Burchum, 2021). It is also essential to evaluate the off-label drug’s side effects and advise the patient to immediately report in case of experiencing any harmful effects (Rosenthal & Burchum, 2021). It is also needed that the pharmacy sector comes up with a solution for calculating the dosage of the off-label drug for children with ADHD. Conclusion Some off-label drugs require extra care before prescribing them to a patient. They possess a potency to affect a child’s liver and brain, thus requiring that nurses be extra careful when prescribing off-label medication. Therefore, despite the prescription of the off-label medication counting as a prevalent practice, it is essential to ensure that one is mindful that it can cause a serious effect on a patient. The best way to make the practice safe is by conducting a clinical trial and looking for the drug’s evidence-based practice. References García-López, I., Vendrell, M. C. M., Romero, I. M., de Noriega, I., González, J. B., & Martino-Alba, R. (2020). Off-label and unlicensed drugs in pediatric palliative care: a prospective observational study. Journal of Pain and Symptom Management, 60(5), 923-932. https://www.sciencedirect.com/science/article/pii/S0885392420305297
Get 20% discount on your first order